[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Sharma et al., 2017 - Google Patents

Cardiovascular Neurohormonal Regulation: A novel role for miR-133a in centrally mediated activation of the renin-angiotensin system in congestive heart failure

Sharma et al., 2017

View HTML
Document ID
18079069107126565351
Author
Sharma N
Nandi S
Zheng H
Mishra P
Patel K
Publication year
Publication venue
American Journal of Physiology-Heart and Circulatory Physiology

External Links

Snippet

An activated renin-angiotensin system (RAS) within the central nervous system has been implicated in sympathoexcitation during various disease conditions including congestive heart failure (CHF). In particular, activation of the RAS in the paraventricular nucleus (PVN) …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Similar Documents

Publication Publication Date Title
DuPont et al. The role of the mineralocorticoid receptor in the vasculature
Sharma et al. A novel role for miR-133a in centrally mediated activation of the renin-angiotensin system in congestive heart failure
Mu et al. Cytoskeleton stiffness regulates cellular senescence and innate immune response in Hutchinson–Gilford Progeria Syndrome
Belevych et al. MicroRNA-1 and-133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex
Sunadome et al. ERK5 regulates muscle cell fusion through Klf transcription factors
Huang et al. Dual regulation of miRNA biogenesis generates target specificity in neurotrophin-induced protein synthesis
Williamson et al. A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain
Liu et al. MicroRNA-17-92 cluster mediates the proliferation and survival of neural progenitor cells after stroke
Chen et al. CDKL5, a protein associated with rett syndrome, regulates neuronal morphogenesis via Rac1 signaling
Pintchovski et al. The serum response factor and a putative novel transcription factor regulate expression of the immediate-early gene Arc/Arg3. 1 in neurons
Chang et al. The tumor suppressor PTPRK promotes ZNRF3 internalization and is required for Wnt inhibition in the Spemann organizer
Celik et al. Antisense regulation of atrial natriuretic peptide expression
Mihalas et al. Opposing action of nuclear factor κB and Polo-like kinases determines a homeostatic end point for excitatory synaptic adaptation
Sugitani et al. A distinct effect of transient and sustained upregulation of cellular factor XIII in the goldfish retina and optic nerve on optic nerve regeneration
Wei et al. GCH1 attenuates cardiac autonomic nervous remodeling in canines with atrial‐tachypacing via tetrahydrobiopterin pathway regulated by microRNA‐206
Yang et al. Involvement of vascular peroxidase 1 in angiotensin II–induced hypertrophy of H9c2 cells
Pan et al. MicroRNA-130b attenuates dexamethasone-induced increase of lipid accumulation in porcine preadipocytes by suppressing PPAR-γ expression
Wang et al. Neuropeptide Y mediates cardiac hypertrophy through microRNA-216b/FoxO4 signaling pathway
JP5686730B2 (en) Methods and pharmaceutical compositions for inhibiting, delaying and / or preventing cardiac hypertrophy
Waugh et al. Association between regulator of G protein signaling 9–2 and body weight
Lei et al. Obesity associated Lyplal1 gene is regulated in diet induced obesity but not required for adipocyte differentiation
Bhat et al. Dyrk1b promotes autophagy during skeletal muscle differentiation by upregulating 4e-bp1
Bardsley et al. Angiotensin peptide synthesis and cyclic nucleotide modulation in sympathetic stellate ganglia
Zhang et al. LncRNA ENSMUST00000155383 is involved in the improvement of DPP-4 inhibitor MK-626 on vascular endothelial function by modulating Cacna1c-mediated Ca2+ influx in hypertensive mice
Sharma et al. Cardiovascular Neurohormonal Regulation: A novel role for miR-133a in centrally mediated activation of the renin-angiotensin system in congestive heart failure